ProPhase Labs Reports Q2 2025 Results: Net Revenues Decrease to $1.25M, Net Loss Per Share Improves to $0.11
Reuters
Aug 13
ProPhase Labs Reports Q2 2025 Results: Net Revenues Decrease to $1.25M, Net Loss Per Share Improves to $0.11
ProPhase Labs Inc. has released its financial results for the three months ending June 30, 2025. The company reported net revenues of $1.247 million, a decrease from $1.504 million in the same period of the previous year. The gross profit for the quarter stood at $734,000, showing a significant improvement compared to a loss of $155,000 in the previous year. Operating expenses decreased to $4.628 million from $7.073 million, leading to a reduced loss from operations of $3.894 million compared to $7.228 million in the prior year. The net loss per share was reported at $0.11, an improvement from a loss of $0.33 per share in the previous year. ProPhase Labs Inc. did not provide any outlook or guidance in the current release.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProPhase Labs Inc. published the original content used to generate this news brief on August 13, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.